BRÈVE

sur Zomedica Corp. (NASDAQ:ZOM)

Zomedica Expands Roswell Facility to Increase Manufacturing Capacity

Graphique de l'évolution du cours de l'action Zomedica Corp. (EBR:ZOM).

Zomedica Corp. (NYSE American:ZOM), a veterinary health company, has completed the expansion of its manufacturing and distribution facilities in Roswell, Georgia. This expansion increases the facility size to 18,400 sq. ft., adding 6,000 sq. ft., and enhancing warehouse and sales order fulfillment efficiencies. The increased capacity supports the growing demand for Zomedica's products.

Tony Blair, Executive Vice President and COO, notes that the additional warehousing and order fulfillment capacity will improve efficiencies. The Roswell facility is managed by a team with extensive operational experience, ensuring the capacity increase and streamlined distribution for current and future products.

Zomedica's Roswell facility manufactures key products including TRUVIEWTM, VetGuardian®, Assisi®, PulseVet®, and TRUFORMA® instruments. TRUFORMA® cartridges are produced at the Plymouth, Minnesota facility. CEO Larry Heaton is pleased with the progress at Roswell, stating that the expansion aligns with the company's rapid sales growth and commitment to meeting customer demand.

R. E.

Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés. Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.

Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève

Voir toutes les actualités de Zomedica Corp.